Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Looked at Q3 filing on Sedar again

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Apr 15, 2023 7:56am

123 Views

Post# 35396487

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Looked at Q3 filing on Sedar again

Paranoia.... we are waiting for more results presented during next AUA, next financial, possible positive outcome from FDA... promoters my a...! A couple weeks to go and we will see where stand. GL

<< Previous

Bullboard Posts

Next >>

AI companies to invest in